|
2011 |
Development of potent μ and δ opioid agonists with high lipophilicity. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2008 |
Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells. |
|
|
2014 |
Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides. |
|
|
2014 |
Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury. |
|
|
2012 |
Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. |
John M. Streicher, PhD |
|
2015 |
Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2011 |
Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2014 |
Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. |
Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD |
|
2022 |
Discovery of Levesquamide B through Global Natural Product Social Molecular Networking. |
Christopher Cartmell |
|
2015 |
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2012 |
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy. |
John M. Streicher, PhD |
|
2016 |
Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. |
Frank Porreca, PhD |
|
2022 |
Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved Antinociceptive Effect after Peripheral Administration. |
John M. Streicher, PhD |
|
2013 |
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. |
Patrick W Mantyh, Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2002 |
Diverse actions of ovarian steroids in the serotonin neural system. |
John M. Streicher, PhD |
|
2008 |
DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. |
|
|
2022 |
Draft Genome Sequence of sp. Strain RKCA744, Isolated from the Arauca River, Colombia. |
Christopher Cartmell |
|
2014 |
Drug delivery to the ischemic brain. |
Patrick T Ronaldson, PhD, FAAPS |
|
2020 |
Dynamic Neuroimmune Profile during Mid-life Aging in the Female Brain and Implications for Alzheimer Risk. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2016 |
Dynorphin A analogs for the treatment of chronic neuropathic pain. |
|
|
2022 |
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. |
Edita Navratilova, Frank Porreca, PhD |
|
2013 |
Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. |
Roberta Diaz Brinton, Ph.D |
|
2013 |
Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2022 |
Editorial: Chronic orofacial pain. |
Frank Porreca, PhD |
